G01N 2333/7151
For tumor necrosis factor [tnf]
Official title: for tumor necrosis factor [TNF]; for lymphotoxin [LT]
G01N2333/7151 (For tumor necrosis factor [tnf]) appears on 51 US grants and 105 published applications in this corpus.
Search patents in G01N- Granted patents
- 51
- Published applications
- 105
- Assignees
- 57
- Inventors
- 220
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 3 |
| 2012 | 1 | 2 |
| 2013 | 2 | 2 |
| 2014 | 0 | 6 |
| 2015 | 0 | 10 |
| 2016 | 4 | 7 |
| 2017 | 3 | 4 |
| 2018 | 6 | 12 |
| 2019 | 6 | 10 |
| 2020 | 5 | 5 |
| 2021 | 8 | 6 |
| 2022 | 3 | 9 |
| 2023 | 2 | 5 |
| 2024 | 4 | 11 |
| 2025 | 4 | 8 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for diagnosing human T-cell leukemia virus type 1 (HTLV-1)-related disease16 Jun 2026US 12,656,345 B2NEC Corporation
- Agonistic tumor necrosis factor receptor superfamily polypeptides30 Dec 2025US 12,509,521 B2The General Hospital Corporation
- Complexes between CD40 and compounds comprising benzimidazole moieties18 Nov 2025US 12,474,348 B2Ucb Biopharma Srl
- Anti-TNFR2 antibody and use thereof13 May 2025US 12,297,284 B2Jiangsu Simcere Pharmaceutical Co., Ltd.
- Agonistic anti-tumor necrosis factor receptor 2 antibodies8 Apr 2025US 12,269,891 B2The General Hospital Corporation
- Clinical application of sbcma in cerebrospinal fluid in diagnosis and monitoring of central nervous system autoimmune diseases25 Jun 2026US 2026/0177550 A1Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Biomarkers8 Jan 2026US 2026/0009802 A1Oxford University Innovation Limited
- Agonistic tumor necrosis factor receptor superfamily polypeptides4 Dec 2025US 2025/0368748 A1The General Hospital Corporation
- Assay and methods for drug discovery6 Nov 2025US 2025/0340941 A1BIOVIE, Inc.
- Precision medicine for treatment of kidney function decline16 Oct 2025US 2025/0321233 A1Joslin Diabetes Center, Inc.
Most cited
By later US patents
- Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof32US 9,228,016 B2Bristol-Myers Squibb Company · 2016
- Method for the selection of antibodies against BCMA18US 9,963,513 B2Engmab SàRl · 2018
- TNF-α binding proteins12US 9,226,983 B2AbbVie Inc. · 2016
- Atypical hemolytic uremic syndrome (AHUS) biomarker proteins11US 9,494,601 B2Alexion Pharmaceuticals, Inc. · 2016
- Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof11US 9,745,379 B2Bristol-Myers Squibb Company · 2017